Report

Global Spatial OMICS Market, By Sample Type (FFPE, Fresh Frozen), By End Use (Academic & Translational Research Institutes, Pharmaceutical and Biotechnology Companies), By Technology (Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics), By Product (Instruments, Consumables, Software), By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis), Estimation & Forecast, 2018 2028

  • Publish Date: Mar,2022
  • Report ID: QI036
  • Page : 179
  • Report Type : PDF (Email)
Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.6. Data Triangulation
Chapter 3. Executive Summary: Global Spatial OMICS Market
Chapter 4. Global Spatial OMICS Market Overview
4.1. Drivers
4.1.1. Growing potential of spatial OMICS as a cancer diagnostic tools
4.1.2. Increasing adoption of spatial OMICS in drug discovery and development
4.2. Restraints
4.2.1. Lack of skilled professionals
4.3. Opportunities
4.3.1. Growing usage of spatial OMICS for biomarker identification
4.4. Impact of COVID-19 on Spatial OMICS Market
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
Chapter 5. Spatial OMICS Market Analysis, By Sample Type
5.1. Key Insights
5.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
5.2.1. FFPE
5.2.2. Fresh Frozen
Chapter 6. Spatial OMICS Market Analysis, By End-Use
6.1. Key Insights
6.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
6.2.1. Academic & Translational Research Institutes
6.2.2. Pharmaceutical and Biotechnology Companies
Chapter 7. Spatial OMICS Market Analysis, By Technology
7.1. Key Insights
7.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
7.2.1. Spatial Proteomics
7.2.2. Spatial Transcriptomics
7.2.3. Spatial Genomics
Chapter 8. Spatial OMICS Market Analysis, By Product
8.1. Key Insights
8.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
8.2.1. Instruments
8.2.2. Consumables
8.2.3. Software
Chapter 9. Spatial OMICS Market Analysis, By Workflow
9.1. Key Insights
9.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
9.2.1. Sample Preparation
9.2.2. Instrumental Analysis
9.2.3. Data Analysis
Chapter 10. Spatial OMICS Market Analysis, By Region/Country
10.1. Key Insights
10.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Germany
10.2.2.2. France
10.2.2.3. U.K.
10.2.2.4. Rest of Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. Rest of Asia Pacific
10.2.4. ROW
10.2.4.1. Latin America
10.2.4.2. Middle East and Africa
Chapter 11. North America Spatial OMICS Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
11.2.1. By Sample Type
11.2.2. By End-Use
11.2.3. By Technology
11.2.4. By Product
11.2.5. By Workflow
11.2.6. By Country
Chapter 12. Europe Spatial OMICS Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
12.2.1. By Sample Type
12.2.2. By End-Use
12.2.3. By Technology
12.2.4. By Product
12.2.5. By Workflow
12.2.6. By Country
Chapter 13. Asia Pacific Spatial OMICS Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
13.2.1. By Sample Type
13.2.2. By End-Use
13.2.3. By Technology
13.2.4. By Product
13.2.5. By Workflow
13.2.6. By Country
Chapter 14. MEA Spatial OMICS Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
14.2.1. By Sample Type
14.2.2. By End-Use
14.2.3. By Technology
14.2.4. By Product
14.2.5. By Workflow
14.2.6. By Country
Chapter 15. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
15.1. 10x Genomics
15.2. S2 Genomics, Inc.
15.3. NanoString Technologies
15.4. Seven Bridges Genomics
15.5. PerkinElmer, Inc.
15.6. Bio-Techne
15.7. Danaher Corporation
15.8. IonPath, Inc.
14.2.5. By Workflow
14.2.6. By Country
Chapter 15. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
15.1. 10x Genomics
15.2. S2 Genomics, Inc.
15.3. NanoString Technologies
15.4. Seven Bridges Genomics
15.5. PerkinElmer, Inc.
15.6. Bio-Techne
15.7. Danaher Corporation
15.8. IonPath, Inc.
15.9. Millennium Science Pty Ltd
15.10. Akoya Biosciences, Inc.
15.11. Fluidigm Corporation
15.12. Diagenode Diagnostics
15.13. Biognosys AG
15.14. Rebus Biosystems
15.15. Ultivue, Inc.
15.16. BioSpyder Technologies
15.17. Bruker